C12N 9/1007
Methyltransferases
Official title: {Methyltransferases (general) (2.1.1.)}
C12N9/1007 (Methyltransferases) appears on 776 US grants and 1,043 published applications in this corpus.
Search patents in C12N- Granted patents
- 776
- Published applications
- 1,043
- Assignees
- 534
- Inventors
- 2,278
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 14 | 0 |
| 1992 | 7 | 0 |
| 1993 | 19 | 0 |
| 1994 | 14 | 0 |
| 1995 | 6 | 0 |
| 1996 | 9 | 0 |
| 1997 | 15 | 0 |
| 1998 | 23 | 0 |
| 1999 | 16 | 0 |
| 2000 | 17 | 0 |
| 2001 | 23 | 1 |
| 2002 | 30 | 31 |
| 2003 | 17 | 39 |
| 2004 | 9 | 25 |
| 2005 | 12 | 31 |
| 2006 | 16 | 31 |
| 2007 | 12 | 17 |
| 2008 | 19 | 25 |
| 2009 | 14 | 27 |
| 2010 | 21 | 27 |
| 2011 | 17 | 36 |
| 2012 | 16 | 27 |
| 2013 | 17 | 31 |
| 2014 | 20 | 38 |
| 2015 | 27 | 44 |
| 2016 | 26 | 46 |
| 2017 | 36 | 49 |
| 2018 | 35 | 46 |
| 2019 | 46 | 48 |
| 2020 | 29 | 51 |
| 2021 | 37 | 49 |
| 2022 | 25 | 51 |
| 2023 | 19 | 59 |
| 2024 | 38 | 78 |
| 2025 | 37 | 74 |
| 2026 | 31 | 62 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Transformed plant having blue flower color, and method for creating same29 Sep 2026US 12,747,447 B2Suntory Holdings Limited
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- Genetic engineering of fungi to modulate tryptamine expression22 Sep 2026US 12,742,160 B2Empyrean Neuroscience, Inc.
- Culture compositions and methods of their use for high yield production of vanillin22 Sep 2026US 12,742,186 B2Amyris, Inc.
- Compositions and methods of treating age-related retinal dysfunction18 Aug 2026US 12,708,616 B2The Regents of the University of California
- Epigenetic repression protein therapy for rasopathies8 Oct 2026US 2026/0306675 A1Battelle Memorial Institute
- Compositions and methods for epigenetic regulation of pcsk9 expression24 Sep 2026US 2026/0284228 A1nChroma Bio, Inc.
- Fusion proteins for epigenetic regulation24 Sep 2026US 2026/0286319 A1nChroma Bio, Inc.
- Method of producing styrylpyrones and chalcones24 Sep 2026US 2026/0286375 A1Nicoventures Trading Limited
- Class 2, type v crispr systems17 Sep 2026US 2026/0275332 A1Metagenomi Therapeutics, Inc.
Most cited
By later US patents
- Methods and materials for making and using transgenic dicamba-degrading organisms1,215US 8,629,323 B2Board of Regents of the University of Nebraska · 2014
- Methods and materials for making and using transgenic dicamba-degrading organisms1,214US 7,812,224 B2Board of Regents of the University of Nebraska · 2010
- Methods and materials for making and using transgenic dicamba-degrading organisms1,208US 8,119,380 B2Board of Regents of the University of Nebraska · 2012
- Methods and compositions for polypeptide engineering338US 6,586,182 B1Maxygen, Inc. · 2003
- Methods and compositions for polypeptide engineering217US 6,303,344 B1Maxygen, Inc. · 2001